Cargando…

Fracture prevention by screening for high fracture risk: a systematic review and meta-analysis

This systematic review and meta-analysis showed a significant reduction of (major) osteoporotic fractures and hip fractures after screening using fracture risk assessment and bone densitometry compared with usual care. The results indicate that screening is effective for fracture risk reduction, esp...

Descripción completa

Detalles Bibliográficos
Autores principales: Merlijn, T., Swart, K.M.A., van der Horst, H.E., Netelenbos, J.C., Elders, P.J.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7010619/
https://www.ncbi.nlm.nih.gov/pubmed/31838551
http://dx.doi.org/10.1007/s00198-019-05226-w
_version_ 1783495903193071616
author Merlijn, T.
Swart, K.M.A.
van der Horst, H.E.
Netelenbos, J.C.
Elders, P.J.M.
author_facet Merlijn, T.
Swart, K.M.A.
van der Horst, H.E.
Netelenbos, J.C.
Elders, P.J.M.
author_sort Merlijn, T.
collection PubMed
description This systematic review and meta-analysis showed a significant reduction of (major) osteoporotic fractures and hip fractures after screening using fracture risk assessment and bone densitometry compared with usual care. The results indicate that screening is effective for fracture risk reduction, especially hip fractures. To perform a systematic review and meta-analysis of population screening for high fracture risk on fracture prevention compared with usual care. MEDLINE and Embase were searched for studies published until June 20th 2019. Randomized studies were selected that screened for high fracture risk using at least bone densitometry, screened in a general population, provided subsequent treatment with anti-osteoporosis medication, had a usual care group as comparator, and had at least one fracture-related outcome (all fractures, (major) osteoporotic fractures, or hip fractures). The primary assessment was the hazard ratio (HR) for fracture-related outcomes. All-cause mortality was a secondary outcome. Random-effects models were used to estimate pooled HRs. We identified 1186 potentially eligible articles and included three randomized studies: the ROSE study, the SCOOP study, and the SOS with a total number of N = 42,009 participants. Respectively, 11%, 15%, and 18% of the participants in the intervention group started medication. Meta-analysis showed a statistically significant and clinically relevant reduction of osteoporotic fractures (HR = 0.95, 95% confidence interval (CI) = 0.89–1.00), major osteoporotic fractures (HR = 0.91; 95%CI = 0.84–0.98), and hip fractures (HR = 0.80; 95%CI = 0.71–0.91), but no reduction of all fractures (HR = 0.95; 95%CI = 0.89–1.02). The pooled HR for the secondary outcome all-cause mortality was 1.04 (95% CI = 0.95–1.14). Numbers needed to screen to prevent one fracture were 247 and 272 for osteoporotic fractures and hip fractures, respectively (corresponding to 113 and 124 performed bone densitometry examinations, and 25 and 28 persons being treated). This meta-analysis showed that population screening is effective to reduce osteoporotic fractures and hip fractures. Implementation of screening in older women should be considered as serious option to prevent osteoporotic fractures, especially hip fractures.
format Online
Article
Text
id pubmed-7010619
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer London
record_format MEDLINE/PubMed
spelling pubmed-70106192020-02-24 Fracture prevention by screening for high fracture risk: a systematic review and meta-analysis Merlijn, T. Swart, K.M.A. van der Horst, H.E. Netelenbos, J.C. Elders, P.J.M. Osteoporos Int Review This systematic review and meta-analysis showed a significant reduction of (major) osteoporotic fractures and hip fractures after screening using fracture risk assessment and bone densitometry compared with usual care. The results indicate that screening is effective for fracture risk reduction, especially hip fractures. To perform a systematic review and meta-analysis of population screening for high fracture risk on fracture prevention compared with usual care. MEDLINE and Embase were searched for studies published until June 20th 2019. Randomized studies were selected that screened for high fracture risk using at least bone densitometry, screened in a general population, provided subsequent treatment with anti-osteoporosis medication, had a usual care group as comparator, and had at least one fracture-related outcome (all fractures, (major) osteoporotic fractures, or hip fractures). The primary assessment was the hazard ratio (HR) for fracture-related outcomes. All-cause mortality was a secondary outcome. Random-effects models were used to estimate pooled HRs. We identified 1186 potentially eligible articles and included three randomized studies: the ROSE study, the SCOOP study, and the SOS with a total number of N = 42,009 participants. Respectively, 11%, 15%, and 18% of the participants in the intervention group started medication. Meta-analysis showed a statistically significant and clinically relevant reduction of osteoporotic fractures (HR = 0.95, 95% confidence interval (CI) = 0.89–1.00), major osteoporotic fractures (HR = 0.91; 95%CI = 0.84–0.98), and hip fractures (HR = 0.80; 95%CI = 0.71–0.91), but no reduction of all fractures (HR = 0.95; 95%CI = 0.89–1.02). The pooled HR for the secondary outcome all-cause mortality was 1.04 (95% CI = 0.95–1.14). Numbers needed to screen to prevent one fracture were 247 and 272 for osteoporotic fractures and hip fractures, respectively (corresponding to 113 and 124 performed bone densitometry examinations, and 25 and 28 persons being treated). This meta-analysis showed that population screening is effective to reduce osteoporotic fractures and hip fractures. Implementation of screening in older women should be considered as serious option to prevent osteoporotic fractures, especially hip fractures. Springer London 2019-12-14 2020 /pmc/articles/PMC7010619/ /pubmed/31838551 http://dx.doi.org/10.1007/s00198-019-05226-w Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Review
Merlijn, T.
Swart, K.M.A.
van der Horst, H.E.
Netelenbos, J.C.
Elders, P.J.M.
Fracture prevention by screening for high fracture risk: a systematic review and meta-analysis
title Fracture prevention by screening for high fracture risk: a systematic review and meta-analysis
title_full Fracture prevention by screening for high fracture risk: a systematic review and meta-analysis
title_fullStr Fracture prevention by screening for high fracture risk: a systematic review and meta-analysis
title_full_unstemmed Fracture prevention by screening for high fracture risk: a systematic review and meta-analysis
title_short Fracture prevention by screening for high fracture risk: a systematic review and meta-analysis
title_sort fracture prevention by screening for high fracture risk: a systematic review and meta-analysis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7010619/
https://www.ncbi.nlm.nih.gov/pubmed/31838551
http://dx.doi.org/10.1007/s00198-019-05226-w
work_keys_str_mv AT merlijnt fracturepreventionbyscreeningforhighfractureriskasystematicreviewandmetaanalysis
AT swartkma fracturepreventionbyscreeningforhighfractureriskasystematicreviewandmetaanalysis
AT vanderhorsthe fracturepreventionbyscreeningforhighfractureriskasystematicreviewandmetaanalysis
AT netelenbosjc fracturepreventionbyscreeningforhighfractureriskasystematicreviewandmetaanalysis
AT elderspjm fracturepreventionbyscreeningforhighfractureriskasystematicreviewandmetaanalysis